• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Erasca, Inc. - Common Stock (NQ:ERAS)

9.620 +0.060 (+0.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,687,932
Open 9.520
Bid (Size) 9.400 (300)
Ask (Size) 9.820 (100)
Prev. Close 9.560
Today's Range 9.085 - 9.870
52wk Range 1.010 - 9.870
Shares Outstanding 151,043,118
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Erasca Insider Sells $671K as Stock Jumps 189% This Past Year ↗
January 13, 2026
This oncology biotech developing targeted cancer therapies saw a key insider significantly trim their direct equity stake. 
Via The Motley Fool
Topics Regulatory Compliance
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
January 08, 2026
Via Chartmill

Performance

YTD
+168.0%
+168.0%
1 Month
+164.3%
+164.3%
3 Month
+297.5%
+297.5%
6 Month
+541.3%
+541.3%
1 Year
+417.2%
+417.2%

More News

Read More
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
ERAS Stock Earnings: Erasca Misses EPS for Q2 2024 ↗
August 12, 2024
Via InvestorPlace
News headline image
ERAS Stock Earnings: Erasca Misses EPS for Q1 2024 ↗
May 08, 2024
Via InvestorPlace
News headline image
ERAS Stock Earnings: Erasca Beats EPS for Q4 2023 ↗
March 27, 2024
Via InvestorPlace
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
January 08, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
January 07, 2026
Via Chartmill
News headline image
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
November 19, 2025
Via FinancialNewsMedia
News headline image
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
November 19, 2025
From FN Media Group LLC
Via GlobeNewswire
News headline image
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
October 02, 2025
Via Benzinga
News headline image
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket ↗
October 02, 2025
Via Benzinga
News headline image
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
September 03, 2025
Via Benzinga
News headline image
Erasca Narrows Loss 46% in Fiscal Q2 ↗
August 12, 2025
Via The Motley Fool
News headline image
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday ↗
April 21, 2025
Via Benzinga
News headline image
This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
March 26, 2025
Via Benzinga
News headline image
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
December 02, 2024
Via Benzinga
News headline image
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday ↗
May 23, 2024
Via Benzinga
News headline image
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗
May 23, 2024
Via Benzinga
News headline image
DXC Technology Issues Weak Outlook, Joins Take-Two Interactive And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
May 17, 2024
Via Benzinga
News headline image
Erasca Reports First Quarter 2024 Business Updates and Financial Results
May 08, 2024
From Erasca, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
April 19, 2024
Via Benzinga
News headline image
Erasca Announces $45 Million Oversubscribed Private Placement Financing
March 27, 2024
From Erasca, Inc.
Via GlobeNewswire
News headline image
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
March 27, 2024
From Erasca, Inc.
Via GlobeNewswire
News headline image
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
February 14, 2024
From Erasca, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Erasca, Inc. - Common Stock publicly traded?
Yes, Erasca, Inc. - Common Stock is publicly traded.
What exchange does Erasca, Inc. - Common Stock trade on?
Erasca, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Erasca, Inc. - Common Stock?
The ticker symbol for Erasca, Inc. - Common Stock is ERAS on the Nasdaq Stock Market
What is the current price of Erasca, Inc. - Common Stock?
The current price of Erasca, Inc. - Common Stock is 9.620
When was Erasca, Inc. - Common Stock last traded?
The last trade of Erasca, Inc. - Common Stock was at 01/16/26 04:00 PM ET
What is the market capitalization of Erasca, Inc. - Common Stock?
The market capitalization of Erasca, Inc. - Common Stock is 1.45B
How many shares of Erasca, Inc. - Common Stock are outstanding?
Erasca, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap